{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:06:20Z","timestamp":1789628780951,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000777","name":"University of Leeds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000777","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS-IBSRF-21-25071"],"award-info":[{"award-number":["FS-IBSRF-21-25071"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/17\/84\/33372"],"award-info":[{"award-number":["PG\/17\/84\/33372"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/13\/3\/29924"],"award-info":[{"award-number":["PG\/13\/3\/29924"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology Plus"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jmccpl.2026.100857","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:32:45Z","timestamp":1784302365000},"page":"100857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The \u03b21 adrenoceptor (AR) blocker metoprolol normalises \u03b2AR cascade and caveolar protein expression and restores \u03b21AR responsiveness in failing right ventricular myocytes"],"prefix":"10.1016","volume":"17","author":[{"given":"Ruth","family":"Norman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Stones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia S.","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Calaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan D.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmccpl.2026.100857_bb0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0010","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0015","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95240","article-title":"Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial","volume":"2","author":"Farha","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0020","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy","volume":"58","author":"van de Veerdonk","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0025","first-page":"489","article-title":"Emerging therapies and future directions in pulmonary arterial hypertension","volume":"31","author":"Gurtu","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts","volume":"307","author":"Bristow","year":"1982","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jmccpl.2026.100857_bb0035","first-page":"15","article-title":"Changes in the receptor-G protein-adenylyl cyclase system in heart failure from various types of heart muscle disease","volume":"87","author":"Bristow","year":"1992","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0040","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI119770","article-title":"Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium","volume":"100","author":"Lowes","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0045","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1164\/rccm.200912-1856OC","article-title":"Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension","volume":"181","author":"Ciarka","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0050","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMoa012630","article-title":"Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents","volume":"346","author":"Lowes","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0055","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0065","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1164\/rccm.201311-2025LE","article-title":"Treatment of group I pulmonary arterial hypertension with carvedilol is safe","volume":"189","author":"Grinnan","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021518","article-title":"Carvedilol for treatment of right ventricular dysfunction in pulmonary arterial hypertension","volume":"10","author":"Thenappan","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0075","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.chest.2024.10.051","article-title":"Effects of \u03b2-blockers on the outcomes in patients with pulmonary arterial hypertension stratified by the presence of comorbid conditions: a multicenter prospective cohort study: the database of pulmonary hypertension in the polish population (BNP-PL)","volume":"167","author":"Walig\u00f3ra","year":"2025","journal-title":"CHEST"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0080","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1164\/rccm.201003-0335OC","article-title":"Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats","volume":"182","author":"Bogaard","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCHEARTFAILURE.111.964494","article-title":"Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension","volume":"5","author":"de Man","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0090","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/CIRCRESAHA.116.308964","article-title":"Genetically encoded biosensors reveal PKA hyperphosphorylation on the myofilaments in rabbit heart failure","volume":"119","author":"Barbagallo","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yjmcc.2013.12.003","article-title":"Caveolin-3 regulates compartmentation of cardiomyocyte beta2-adrenergic receptor-mediated cAMP signaling","volume":"67","author":"Wright","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2018.05.015","article-title":"Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca2+ handling dysfunction in rats with pulmonary artery hypertension","volume":"120","author":"Fowler","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0105","doi-asserted-by":"crossref","first-page":"H2230","DOI":"10.1152\/ajpheart.01226.2010","article-title":"Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy","volume":"300","author":"Benoist","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081805","article-title":"Energy metabolism in the failing right ventricle: limitations of oxygen delivery and the creatine kinase system","volume":"20","author":"Fowler","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2015.06.016","article-title":"Decreased creatine kinase is linked to diastolic dysfunction in rats with right heart failure induced by pulmonary artery hypertension","volume":"86","author":"Fowler","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0120","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.yjmcc.2011.06.014","article-title":"Caveolae compartmentalise \u03b22-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte","volume":"52","author":"Macdougall","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0125","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1210\/endo.139.4.5957","article-title":"Inhibition of adenylyl cyclase by caveolin peptides","volume":"139","author":"Toya","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0130","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/cvr\/cvx151","article-title":"Hierarchical statistical techniques are necessary to draw reliable conclusions from analysis of isolated cardiomyocyte studies","volume":"113","author":"Sikkel","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"Suppl. 1","key":"10.1016\/j.jmccpl.2026.100857_bb0135","first-page":"S379","article-title":"Agonist-selective mechanisms of GPCR desensitization","volume":"153","author":"Kelly","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0140","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.CIR.98.17.1783","article-title":"Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade","volume":"98","author":"Iaccarino","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0145","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1242\/jcs.167866","article-title":"Cavin family proteins and the assembly of caveolae","volume":"128","author":"Kovtun","year":"2015","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.yjmcc.2011.02.007","article-title":"Local control of \u03b2-adrenergic stimulation: effects on ventricular myocyte electrophysiology and Ca2+\u2212transient","volume":"50","author":"Heijman","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00005344-200303000-00001","article-title":"Cardiac \u03b2-adrenoceptor changes in monocrotaline-treated rats: differences between membrane preparations from whole ventricles and isolated ventricular cardiomyocytes","volume":"41","author":"Leineweber","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0160","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jacbts.2020.07.011","article-title":"Treatment targets for right ventricular dysfunction in pulmonary arterial hypertension","volume":"5","author":"Prisco","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0165","doi-asserted-by":"crossref","first-page":"R1153","DOI":"10.1152\/ajpregu.00652.2011","article-title":"Cardiac sympathetic activation in patients with pulmonary arterial hypertension","volume":"302","author":"Mak","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0170","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/13993003.01244-2015","article-title":"beta-blockers in pulmonary arterial hypertension: generation might matter","volume":"47","author":"Malenfant","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0175","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1253\/jcj.55.1077","article-title":"Biventricular down-regulation of beta-adrenergic receptors in right ventricular hypertrophy induced by monocrotaline","volume":"55","author":"Ishikawa","year":"1991","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0180","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1006\/jmcc.2000.1262","article-title":"The cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats","volume":"32","author":"Seyfarth","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0185","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI115659","article-title":"Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms","volume":"89","author":"Bristow","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cophys.2017.08.005","article-title":"Caveolae and the cardiac myocyte","volume":"1","author":"Norman","year":"2018","journal-title":"Curr Opin Physiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0195","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/S0002-9440(10)61168-6","article-title":"Caveolin-1\/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype","volume":"160","author":"Park","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162513","article-title":"PTRF\/Cavin-1 deficiency causes cardiac dysfunction accompanied by cardiomyocyte hypertrophy and cardiac fibrosis","volume":"11","author":"Taniguchi","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0205","doi-asserted-by":"crossref","first-page":"H1101","DOI":"10.1152\/ajpheart.00209.2018","article-title":"Caveolin-3 KO disrupts t-tubule structure and decreases t-tubular I(Ca) density in mouse ventricular","volume":"315","author":"Bryant","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0008-6363(02)00660-0","article-title":"Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat","volume":"57","author":"Ratajczak","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0215","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1113\/EP087304","article-title":"Cardiac-specific overexpression of caveolin-3 preserves t-tubular I(Ca) during heart failure in mice","volume":"104","author":"Kong","year":"2019","journal-title":"Exp Physiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0220","doi-asserted-by":"crossref","first-page":"47997","DOI":"10.1074\/jbc.M308362200","article-title":"Modeling beta-adrenergic control of cardiac myocyte contractility in silico","volume":"278","author":"Saucerman","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0225","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00144-2023","article-title":"Beta-blockade improves right ventricular diastolic function in exercising pulmonary arterial hypertension","volume":"61","author":"Samaranayake","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0230","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.yjmcc.2010.11.015","article-title":"Effects of cholesterol depletion on compartmentalized cAMP responses in adult cardiac myocytes","volume":"50","author":"Agarwal","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0235","doi-asserted-by":"crossref","first-page":"31036","DOI":"10.1074\/jbc.M502540200","article-title":"G-protein-coupled receptor signaling components localize in both Sarcolemmal and intracellular Caveolin-3-associated microdomains in adult cardiac myocytes *","volume":"280","author":"Head","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0240","doi-asserted-by":"crossref","first-page":"41447","DOI":"10.1074\/jbc.M006951200","article-title":"Differential targeting of \u03b2-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte Caveolae: a MECHANISM TO FUNCTIONALLY REGULATE THE cAMP SIGNALING PATHWAY *","volume":"275","author":"Rybin","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2026.100857_bb0245","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology","volume":"62","author":"Vonk-Noordegraaf","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jmccpl.2026.100857_bb0250","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.bjp.0703400","article-title":"Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium","volume":"130","author":"Maack","year":"2000","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Molecular and Cellular Cardiology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976126000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976126000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:43:51Z","timestamp":1789627431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772976126000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S2772976126000243"],"URL":"https:\/\/doi.org\/10.1016\/j.jmccpl.2026.100857","relation":{},"ISSN":["2772-9761"],"issn-type":[{"value":"2772-9761","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u03b21 adrenoceptor (AR) blocker metoprolol normalises \u03b2AR cascade and caveolar protein expression and restores \u03b21AR responsiveness in failing right ventricular myocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmccpl.2026.100857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100857"}}